Occlutech takes important step towards approval in China
Occlutech AG (“Occlutech” or the “Company”) today announces that the planned recruitment of 180 patients has been reached in the… Read More »
BioVaxys And Bioproduction Partner Bio Elpida Begin Construction Of GMP Facility To Produce Clinical Supply For Planned Ovarian Cancer Vaccine Study
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (US OTCQB: BVAXF) (“BioVaxys” or “the Company”) is pleased to announce that its… Read More »
GenScript ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII
On June 1st 2021, GenScript ProBio and Neoletix (Beijing) Biotechnology Co., Ltd. (hereinafter referred to as Neoletix) signed a letter… Read More »
Puyi Biotechnology Completes Series B Financing
Puyi (Shanghai) Biotechnology Co., Ltd. (“Puyi Biotechnology”) recently announced the completion of its Series B financing led by Goldman Sachs… Read More »
Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index
Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),… Read More »
China’s First Trastuzumab Biosimilar Approved by NMPA
Shanghai Henlius Biotech, Inc. (2696.HK) announced on August 14 that the trastuzumab biosimilar HLX02, developed and manufactured by Henlius independently,… Read More »
First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody
Ascletis Pharma Inc. (HKEX code: 1672) announces today dosing of the first HBV patient in Phase IIa clinical trial of… Read More »
I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China
I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics,… Read More »